Smoking cessation among inner-city African Americans using the nicotine transdermal patch

Area of Science:

• Public Health
• Clinical Medicine
• Behavioral Science

Background:

• Smoking remains a significant public health issue, particularly in underserved urban communities.
• African Americans in inner-city areas face unique challenges and disparities in accessing effective smoking cessation resources.
• Previous research on smoking cessation interventions in diverse populations has yielded varied results, necessitating targeted studies.

Purpose of the Study:

• To evaluate the effectiveness of the transdermal nicotine patch as a smoking cessation aid.
• To specifically assess efficacy in inner-city African American smokers.
• To determine if the nicotine patch improves quit rates when used with brief counseling.

Main Methods:

• A double-blind, placebo-controlled, randomized trial was conducted.
• 410 inner-city patients interested in quitting smoking were randomized.
• Participants received either a transdermal nicotine patch or a placebo patch for 10 weeks, alongside brief counseling.

Main Results:

• At 10 weeks, the nicotine patch group showed significantly higher quit rates (21.5%) compared to the placebo group (13.7%; p = .03).
• While quit rates at 6 months were higher with the nicotine patch (17.1% vs. 11.7%), this difference was not statistically significant (p = .08).
• Adjusted analyses indicated significant short-term benefits (p = .04 at 10 weeks), but not long-term (p = .14 at 6 months).

Conclusions:

• The transdermal nicotine patch is an effective adjunct for improving short-term smoking cessation rates in inner-city African Americans.
• Smoking cessation programs should actively target and engage underserved populations.
• Strategies to support sustained abstinence are essential for long-term success in these communities.